Skip to main content
. 2022 Aug 13;7(6):101047. doi: 10.1016/j.adro.2022.101047

Table 1.

Patient characteristics

No. of fractions All 1 3 5
No. of lesions 353 270 (76%) 70 (20%) 13 (4%)
Median age, y (range) 67.2 (20-89) 67.9 (30-86) 65.0 (20-87) 61.8 (21-89)
Sex
 Male 265 (75%) 211 (78%) 43 (61%) 11 (85%)
 Female 88 (25%) 59 (22%) 27 (39%) 2 (15%)
ECOG performance status
 0 213 (60%) 166 (61%) 42 (60%) 5 (38%)
 1 107 (30%) 77 (29%) 24 (34%) 6 (46%)
 2 30 (8%) 24 (9%) 4 (6%) 2 (15%)
 3 2 (1%) 2 (1%) 0 (0%) 0 (0%)
 4 1 (0%) 1 (0%) 0 (0%) 0 (0%)
Bilsky grade
 0 268 (76%) 217 (80%) 41 (59%) 10 (77%)
 1 52 (15%) 38 (14%) 14 (20%) 0 (0%)
 2 26 (7%) 10 (4%) 13 (19%) 3 (23%)
 3 7 (2%) 5 (2%) 2 (3%) 0 (0%)
SINS category
 ≤6 214 (61%) 173 (64%) 34 (49%) 7 (54%)
 ≥7 139 (39%) 97 (36%) 36 (51%) 6 (46%)
Location of treatment
 Cervical 70 (19%) 55 (20%) 12 (17%) 3 (23%)
 Cervical + thoracic 3 (1%) 1 (0%) 2 (3%) 0 (0%)
 Thoracic 259 (71%) 192 (71%) 49 (70%) 8 (62%)
 Thoracic + lumbar 2 (1%) 2 (1%) 0 (0%) 0 (0%)
 Lumbar 29 (8%) 20 (20%) 7 (7%) 2 (15%)
No. of lesions treated
 1 268 (76%) 216 (80%) 44 (63%) 8 (62%)
 2 53 (15%) 36 (13%) 15 (21%) 2 (15%)
 3 27 (8%) 17 (6%) 7 (10%) 3 (23%)
 4 5 (1%) 1 (0%) 4 (6%) 0 (0%)
Primary tumor
 Prostate 150 (42%) 136 (50%) 14 (20%) 0 (0%)
 Kidney 56 (16%) 40 (15%) 14 (20%) 2 (15%)
 Endometrial 29 (8%) 24 (9%) 5 (7%) 0 (0%)
 Sarcoma 28 (8%) 13 (5%) 7 (10%) 8 (62%)
 Lung 27 (8%) 16 (6%) 11 (16%) 0 (0%)
 Other 63 (18%) 41 (15%) 19 (27%) 3 (23%)
Histology
 Adenocarcinoma 179 (51%) 153 (57%) 26 (37%) 0 (0%)
 Other 174 (49%) 117 (43%) 44 (63%) 13 (100%)

Abbreviations: ECOG = Eastern Cooperative Oncology Group; SINS = spinal instability neoplastic score.